In the dynamic landscape of cancer research, precise survival prediction at the time of diagnosis stands as a pivotal aspect for informed clinical decision-making.
This study aims to not only predict the survival time of cancer patients but also provide a valuable tool for clinicians, aiding them in crafting personalized treatment strategies.
Through an independent analysis of biological, clinical, and mutational data, this research seeks to empower medical professionals with enhanced insights into the
intricate dynamics of cancer progression.
